Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs NXP Semiconductors N.V. Common Stock (NXPI) Price & Performance

Ginkgo Bioworks Holdings IncTrade
NXP Semiconductors N.V. Common StockTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs NXP Semiconductors N.V. Common Stock — how do they compare? Ginkgo Bioworks Holdings Inc trades at $12.95 (market cap $763.64M), while NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 76.3× Ginkgo Bioworks Holdings Inc's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and NXP Semiconductors N.V. Common Stock for 0 Days on average.

DNANXPI
Market Cap
$763.64M$58.27B
Volume
3,204,1773,950,702
Sector
HealthTechnology
52-Week High
$15.83$332.67
52-Week Low
$5.48$184.19
Typical Hold Time
7 Days0 Days
Enterprise Value
$865.59M$66.38B
Dividend Yield
—1.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.

DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.

NXP Semiconductors N.V. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
NXPI
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About NXP Semiconductors N.V. Common Stock

NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.

Read more on NXPI →